CL
CYTK icon

CSS LLC’s Cytokinetics CYTK Stock Holding History

CSS LLC’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-185
Closed -$3.38K – 860
2020
Q3 		$4K Buy
+185
New +$4.33K ﹤0.01% 785

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

CSS LLC's CYTK Position: Q4 2020 in Review

CSS LLC sold out of Cytokinetics (CYTK) in Q4 2020, closing a stake of 185 shares — an estimated $3.38K sold.

CSS LLC first reported a position in CYTK in Q3 2020 and held it in 1 quarter. The position peaked at $4K in Q3 2020. 178 funds tracked by Wall St. Rank hold CYTK as of Q4 2020.

  • CSS LLC reported no remaining Cytokinetics position as of Q4 2020 after selling out during the quarter.
  • CSS LLC sold 185 Cytokinetics shares in Q4 2020, an estimated $3.38K.
  • CSS LLC first reported a position in Cytokinetics in Q3 2020 and held it in 1 quarter.
  • CSS LLC's Cytokinetics position peaked at $4K in Q3 2020.
  • 178 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2020.

Based on CSS LLC's 13F filing for Q4 2020, filed 16 Feb 2021.